News and Comments

IDERA (IDRA): GOOD NEWS OFFSET SOMEWHAT BY SKEPTICISM NOT PESSIMISM

  Monday, March 04, 2013

Forgetting about Idera Pharmaceuticals (IDRA) seems to make its value sink, but failed to make it disappear. With a stock that sells at less than a three quarter of a dollar and a market of $20 million, lower than a new comer biotech having drugs still in preclinical lab testing, the firm was capable of drawing investors’ attention, riding new data about an attractive possibility of beating all existing approaches to treating psoriasis. The surprising data, which bring hopes in treating other autoimmune diseases, in addition to psoriasis were presented by James G. Krueger, M.D., PhD, of The Rockefeller University, at the Late-Breaking Research Symposium on March 2nd, 2013, during the American Academy of Dermatology Annual Meeting. More...


Recent Postings


Archive


Tags

Trastuzumab-DM1 PTC Therapeutics (PTCT) Agenus (AGEN Onyx (ONXX) SYNTA (SNTA) TOKAI (TKAOI) ARGOS (ARGS) Prosensa (RNA) Aimmune Therapeutics (AIMT) Micromet (MITI) Ionis (IONS) Theravance Bio Pharma (TBPH) Gilead (GILD) JUNO (JUNO) ARCA (ABIO) ImmunoGen (IMGN) Ariad (ARIA) Benlysta (belimumab) Roche (RHHBY) Intercept (ICPT) Theravance (THRX) Herceptin REGULUS (RGLS) galapagos (GLPG) NEKTAR (NKTR)) Valeant Pharmaceuticals International (VRX) Dendreon (DNDN) Biogen Idec (BIIB) PORTOLA (PTLA) Tysabri AGOS (ARGS) Jazz Pharmaceuticals (JAZZ) Sanofi (SNY) Genentech INNOVIVA (INVA) Zerenex GlaxoSmithKline (GSK) Anacor (ANAC) C4 Therapeutics Vitae Pharmaceuticals (VTAE) AERIE PHARMACEUTICALS Merck (MRK) MODERNA Incyte (INCY) Seattle Genetics (SGEN) Multiple Myeloma Sanofi-Aventis (SAN) ADVENTRIX (ANX) Array Pharmaceuticals (ARRY) Prolor Biotech (PBTH) Illumina (ILMN) Roche (ROCHE) CEMPRA (CEMP) VANDA (VNDA) SUNESIS PHARMACEUTICALS (SNSS) NANTKWEST (NK) Sarepta (SRPT) Pluristem (PSTI) Ocular Therapeutix (OCUL) Rapamune Regeneron (REGN) Xoma (XOMA) IDERA (IDRA) Human Longevity (HLI) Mirati Therapeutics (MRTX) Sangamo (SGMO) Ziofpharm (ZIOP) Amgen (AMGN) Abbott Laboratories (ABT) Alnylam (ALNY) CompuGen (CGEN) Agenus (AGEN) Sanofi (SNA) OSI (OSIP) SERES THERAPEUTICS (MCRB) Cytokinetics (CYTK) Revlimid (lenolidamide) ZALTRAP™ AstraZeneca (AZN) KERYX (KERX) CRISPR Therapeutics (CRSP) Sequenom (SQNM) Telaprevir HALOZYME (HALO) BIOMARIN (BMRN) Bristol-Myers Squibb (BMY) Velcade (bortezomib) Vertex (VRTX) Human Genome Sciences (HGSI) Elan (ELN) Ridaforolimus Advaxis (ADXS) RenenxBio (RGNX) LEXICON (LXRX) Spike Therapeutics (ONCE) Bellicum (BLCM) Biocryst (BCRX) JOUNCE THERAPEUTICS (JNCE) OncoCyte (OCX) Dynavax (DVAX) Galena (GALE) Anadys (ANDS) NOVOCURE (NVCR) ACADIA (ACAD) Alder Biopharmaceuticals (ALDR) Adaptimmune (ADAP) KITE (KITE) ABBVIE (ABBV) Exelixis (EXEL) Intrexon (XON) ISIS (ISIS) Idenix (IDIX) Auspex (ASPX) GUARDIAN HEALTH Global Cell Therapeutics (GBT) Editas (EDIT) Endometrial Cancer Intermune (ITMN) Inovio (INO)